These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8744565)

  • 21. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccination against hepatitis A].
    Zamir D; Zamir H; Weiner P
    Harefuah; 1998 Aug; 135(3-4):114-8. PubMed ID: 9885656
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current status of immunity to hepatitis A virus in various adult groups].
    Ibarra H; Riedemann S; Prado V; Reinhardt G; Vega I; Potin M; Frick P
    Rev Med Chil; 1999 Oct; 127(10):1165-8. PubMed ID: 10835731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.
    Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL
    Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea.
    Jang JH; Jung YM; Kim JS; Lee SH; Kim JW; Hwang SG; Rim KS; Park SJ; Park YM; Kang SK; Lee HS; Yun H; Kim JH; Jeong SH
    J Viral Hepat; 2011 Oct; 18(10):e408-14. PubMed ID: 21914057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apparent simultaneous occurrence of hepatitis A and hepatitis B infections].
    Poyraz O; Gökoğlu M; Oztop Y
    Mikrobiyol Bul; 1992 Oct; 26(4):329-32. PubMed ID: 1331719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study.
    Ye C; Luo J; Wang X; Xi J; Pan Y; Chen J; Yang X; Li G; Sun Q; Yang J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2165-2170. PubMed ID: 28631170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of immunoglobulin M antibody to hepatitis A virus and relapse of hepatitis A infection.
    Cornu C; Lamy ME; Geubel A; Galanti L
    Eur J Clin Microbiol; 1984 Feb; 3(1):45-6. PubMed ID: 6705773
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples.
    Oba IT; Spina AM; Saraceni CP; Lemos MF; Senhoras R; Moreira RC; Granato CF
    Rev Inst Med Trop Sao Paulo; 2000; 42(4):197-200. PubMed ID: 10968882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of IgM against hepatitis A virus using tissue culture derived antigen.
    Chitambar SD; Arankalle VA; Banerjee K
    Indian J Med Res; 1991 Jan; 93():19-21. PubMed ID: 1850714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Bohm K; Filomena A; Schneiderhan-Marra N; Krause G; Sievers C
    Vaccine; 2017 Oct; 35(43):5883-5889. PubMed ID: 28919226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].
    Cesur S; Akin K; Doğaroğlu I; Birengel S; Balik I
    Mikrobiyol Bul; 2002 Jan; 36(1):79-83. PubMed ID: 12476770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threat of hepatitis E virus infection in Somalia during Operation Restore Hope.
    Burans JP; Sharp T; Wallace M; Longer C; Thornton S; Batchelor R; Clemens V; Hyams KC
    Clin Infect Dis; 1994 Jan; 18(1):100-2. PubMed ID: 8054416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of anti-HAV IgM and anti-HEV IgM in patients with sporadic acute hepatitis in Beijing between 1995-2000].
    Lu J; Zhao H; Mong Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):157-9. PubMed ID: 11436647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody.
    Alatoom A; Ansari MQ; Cuthbert J
    Arch Pathol Lab Med; 2013 Jan; 137(1):90-5. PubMed ID: 23276180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic urticaria and hepatitis A].
    Chantraine-Hess S; Czarnetzki BM
    Hautarzt; 1995 Dec; 46(12):874. PubMed ID: 8567276
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice.
    Li T; Takeda N; Miyamura T
    Vaccine; 2001 May; 19(25-26):3476-84. PubMed ID: 11348714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.